SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-032825
Filing Date
2024-02-13
Accepted
2024-02-13 06:30:54
Documents
14
Period of Report
2024-02-13
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d787773d8k.htm   iXBRL 8-K 22885
  Complete submission text file 0001193125-24-032825.txt   140430

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA crsp-20240213.xsd EX-101.SCH 2854
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE crsp-20240213_lab.xml EX-101.LAB 17168
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crsp-20240213_pre.xml EX-101.PRE 10791
15 EXTRACTED XBRL INSTANCE DOCUMENT d787773d8k_htm.xml XML 3526
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 24622494
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)